This comparative analysis revealed upregulation of CCT5 in 19 different cancer types, namely BLCA, CESC, CHOL, COAD, DLBC, ESCA, GBM, LGG, LIHC, LUAD, LUSC, OV, PAAD, READ, SKCM, STAD, THYM, UCEC, and UCS, and its downregulation in LAML (Supplementary Fig. 1). Here, CCT5 is linked to cancer.